enfortumab vedotin

Summary

enfortumab vedotin is a type of chemical entity^[1]. It ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (73 views/month).^[2]

Key Facts

• enfortumab vedotin's instance of is recorded as type of chemical entity^[3].
• enfortumab vedotin's chemical structure is recorded as Enfortumab vedotin.svg^[4].
• enfortumab vedotin's CAS Registry Number is recorded as 1346452-25-2^[5].
• enfortumab vedotin's subclass of is recorded as chemical compound^[6].
• enfortumab vedotin's has use is recorded as medication^[7].
• enfortumab vedotin's Guide to Pharmacology Ligand ID is recorded as 10738^[8].
• enfortumab vedotin's Freebase ID is recorded as /m/0136_zd6^[9].
• enfortumab vedotin's UNII is recorded as DLE8519RWM^[10].
• enfortumab vedotin's KEGG ID is recorded as D11525^[11].
• enfortumab vedotin's DrugBank ID is recorded as DB13007^[12].
• enfortumab vedotin's subject has role is recorded as monoclonal antibody^[13].
• enfortumab vedotin's legal status is recorded as boxed warning^[14].
• enfortumab vedotin's UK Parliament thesaurus ID is recorded as 566923^[15].
• enfortumab vedotin's MedlinePlus drug identifier is recorded as a620005^[16].
• enfortumab vedotin's WikiProjectMed ID is recorded as Enfortumab vedotin^[17].
• enfortumab vedotin's NCI Dictionary of Cancer Terms entry is recorded as padcev^[18].

Why It Matters

enfortumab vedotin ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (73 views/month).^[2] It has Wikipedia articles in 9 language editions, a strong signal of global cultural recognition.^[19]